InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Clarke John K, Director. Director active across 2 companies, notably aTYR PHARMA INC. Aggregated, 2 disclosures have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €9k. History available since 21 May 2021. The latest transaction was disclosed on 21 May 2021 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Clarke John K
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
6,000 sharesCommon StockSEC:0001209191-23-026069:0
2,500 shares@ US$4.34100.0% of flowCommon StockSEC:0001209191-21-035836:0
2 of 2 declarations
About Clarke John K
John K. Clarke is a Board Member at aTYR PHARMA INC. He plays a crucial role in the strategic direction of the company, which focuses on developing treatments for rare diseases. His expertise helps guide key decisions for the company's future.
